GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » Capex-to-Revenue

Atrys Health (XMAD:ATRY) Capex-to-Revenue : 0.07 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Atrys Health Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Atrys Health's Capital Expenditure for the six months ended in Dec. 2024 was €-7.10 Mil. Its Revenue for the six months ended in Dec. 2024 was €105.30 Mil.

Hence, Atrys Health's Capex-to-Revenue for the six months ended in Dec. 2024 was 0.07.


Atrys Health Capex-to-Revenue Historical Data

The historical data trend for Atrys Health's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Capex-to-Revenue Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.17 0.07 0.10 0.07 0.06

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.07 0.07 0.06 0.07

Competitive Comparison of Atrys Health's Capex-to-Revenue

For the Biotechnology subindustry, Atrys Health's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Atrys Health's Capex-to-Revenue falls into.


;
;

Atrys Health Capex-to-Revenue Calculation

Atrys Health's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-13.138) / 212.743
=0.06

Atrys Health's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-7.099) / 105.3
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health  (XMAD:ATRY) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Atrys Health Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Atrys Health's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health Business Description

Traded in Other Exchanges
Address
Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health Headlines

No Headlines